HUMACYTE INC's ticker is and the CUSIP is 44486Q103. A total of 76 filers reported holding HUMACYTE INC in Q4 2022. The put-call ratio across all filers is 1.17 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $116,015 | +19.4% | 39,600 | +16.5% | 0.00% | – |
Q2 2023 | $97,203 | +7.5% | 33,985 | +16.3% | 0.00% | – |
Q1 2023 | $90,414 | +55.9% | 29,210 | +5.3% | 0.00% | – |
Q4 2022 | $58,000 | -34.1% | 27,729 | +3.1% | 0.00% | – |
Q3 2022 | $88,000 | +2.3% | 26,904 | +0.2% | 0.00% | – |
Q2 2022 | $86,000 | -51.4% | 26,854 | +7.3% | 0.00% | – |
Q1 2022 | $177,000 | +21.2% | 25,020 | +24.6% | 0.00% | – |
Q4 2021 | $146,000 | -30.8% | 20,074 | +10.2% | 0.00% | – |
Q3 2021 | $211,000 | – | 18,224 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
York Capital Management Global Advisors, LLC | 2,291,397 | $16,177,000 | 4.71% |
Endowment Wealth Management, Inc. | 96,618 | $682,000 | 0.72% |
JOSH ARNOLD INVESTMENT CONSULTANT, LLC | 36,171 | $255,000 | 0.24% |
Prescott General Partners LLC | 625,100 | $4,413,000 | 0.20% |
CenterBook Partners LP | 45,752 | $323,000 | 0.12% |
Gladstone Institutional Advisory LLC | 144,867 | $1,023 | 0.07% |
Exos Asset Management LLC | 18,609 | $131,000 | 0.06% |
Sciencast Management LP | 26,300 | $182,000 | 0.04% |
Y-Intercept (Hong Kong) Ltd | 17,125 | $121,000 | 0.03% |
Kovack Advisors, Inc. | 31,500 | $222,000 | 0.02% |